Axsome Therapeutics (AXSM) Return on Invested Capital (2023 - 2026)

Axsome Therapeutics (AXSM) has 4 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, changed 0.0% from the prior year.
• Return on Invested Capital eased to 0.0% in Q1 2026, from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q4 2025 to a low of 0.0% in Q3 2024.
• A 4-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Invested Capital.
• Peak annual rise in Return on Invested Capital reached 0 bps in 2024, while the deepest fall reached 0 bps in 2024.
• Tracing AXSM's Return on Invested Capital over 4 years: stood at 0.0% in 2023, then declined by 8 bps to 0.0% in 2024, then increased by 25 bps to 0.0% in 2025, then retreated by 30 bps to 0.0% in 2026.
• Business Quant data shows AXSM's Return on Invested Capital at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.